Merck, Schering, Buoyed by Medicare, May Lead Stocks (Update1) (Bloomberg.com)
April 27 (Bloomberg) -- Pharmaceutical stocks are headed for their biggest annual gain since 2000 after a new U.S. drug insurance program and industrywide job cuts helped profits beat analysts' estimates.

A TOUGH YEAR, BUT NO REGRETS (Pioneer Press)
In the year since Boston Scientific bought the Arden Hills heart-device business of Guidant Corp., the company's stock price has fallen by about 30 percent and device sales have dropped.

3 Indian firms get FDA nod for sleep disorder drug (rediff.com)
Ranbaxy Laboratories, Dr Reddy's Laboratories and Sun Pharma's US subsidiary Caraco Pharmaceuticals are among the 13 generic manufacturers to get first generic approvals from the US Food and Drug Administration to manufacture and market generic versi